IDBI Capital: Dabur India Q2 Review - Healthcare, Home & Personal Care Drives Strong Growth In Topline
A range of Dabur India Ltd. products (Photographer: Prashanth Vishwanathan/Bloomberg)  

IDBI Capital: Dabur India Q2 Review - Healthcare, Home & Personal Care Drives Strong Growth In Topline

Bookmark

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

IDBI Capital Report

Dabur India Ltd.’s Q2 FY21 result was above our estimates. Consolidated revenue growth recovered to high double digit after two consecutive quarter of decline.

Health supplement portfolio delivered astronomical 71%YoY revenue growth driven by two times sales of Chyawanprash.

In home and personal care; oral care, hygiene and shampoo portfolio revenue grew at 18-38% rate while revenue from Odomos, Odonil and Hair Oil portfolio declined six to 10%.

Click on the attachment to read the full report:

IDBI Capital Dabur India Q2Fy21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.